However, conflictive with the inhibitory effect, we found higher PEDF expression levels in HCC tissues than matched adjacent non-tumor tissues (Fig. 1a–e), and no correlation between PEDF expression and HCC patient outcomes (Fig. 1g, h). Here, SERPINF1 is linked to hepatocellular carcinoma.